Moderna – Pharmaceutical Manufacturing Ventilation Systems
Implementation of ventilation systems for a state-of-the-art pharmaceutical manufacturing plant.
Ventilation project carried out for a new mRNA vaccine manufacturing plant, designed to reach an annual production capacity of 100 million doses. The work involved the implementation of ventilation systems meeting the high requirements of the pharmaceutical industry in terms of air quality, environmental control, and regulatory compliance.
Pharmaceutical production environment
The ventilation systems were designed to serve critical manufacturing areas, requiring rigorous control of airflow, cleanliness, and ambient conditions to ensure the safety and integrity of production processes.
Industrial performance and capacity
The ventilation infrastructure supports very large-scale production capacity while ensuring the stability of conditions required for mRNA vaccine manufacturing.
Industrial ventilation designed for pharmaceutical production of 100 million doses per year.
